Comments
Loading...
Stime degli utili, EPS e fatturato
Aquestive Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 3
Stima EPS
$-0.120
Stima dei ricavi trimestrali
$13.11M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$44.13M
Analizza lo storico degli utili di Aquestive Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
AQST | Aquestive Therapeutics | -$0.13 | -$0.12 | — | — | $13.54M | $13.11M | — | — | 11/03/2025 | |
AQST | Aquestive Therapeutics | -$0.03 | -$0.18 | -$0.14 | 22.22% | $20.10M | $11.22M | $10.00M | -10.85% | 08/11/2025 | |
AQST | Aquestive Therapeutics | -$0.17 | -$0.16 | -$0.24 | -50.00% | $12.05M | $12.23M | $8.72M | -28.70% | 05/12/2025 | |
AQST | Aquestive Therapeutics | -$0.10 | -$0.13 | -$0.19 | -46.15% | $13.21M | $13.11M | $11.87M | -9.48% | 03/05/2025 | |
AQST | Aquestive Therapeutics | -$0.03 | -$0.13 | -$0.13 | 0.00% | $13.00M | $12.68M | $13.54M | 6.80% | 11/04/2024 | |
AQST | Aquestive Therapeutics | -$0.10 | -$0.12 | -$0.03 | 75.00% | $13.24M | $12.38M | $20.10M | 62.35% | 08/06/2024 | |
AQST | Aquestive Therapeutics | $0.11 | -$0.08 | -$0.17 | -112.50% | $11.13M | $12.26M | $12.05M | -1.69% | 05/07/2024 | |
AQST | Aquestive Therapeutics | -$0.23 | -$0.08 | -$0.10 | -25.00% | $10.68M | $11.63M | $13.21M | 13.55% | 03/05/2024 | |
AQST | Aquestive Therapeutics | -$0.23 | -$0.11 | -$0.03 | 72.73% | $11.46M | $11.51M | $13.00M | 12.96% | 11/06/2023 | |
AQST | Aquestive Therapeutics | -$0.36 | -$0.11 | -$0.10 | 9.09% | $13.27M | $10.76M | $13.24M | 23.06% | 08/07/2023 | |
AQST | Aquestive Therapeutics | -$0.32 | -$0.19 | $0.11 | 157.89% | $12.27M | $9.94M | $11.13M | 12.01% | 05/02/2023 | |
AQST | Aquestive Therapeutics | -$0.38 | -$0.23 | -$0.23 | 0.00% | $11.08M | $10.42M | $10.68M | 2.51% | 03/07/2023 | |
AQST | Aquestive Therapeutics | -$0.37 | -$0.30 | -$0.23 | 23.33% | $13.29M | $11.04M | $11.46M | 3.83% | 11/01/2022 | |
AQST | Aquestive Therapeutics | -$0.33 | -$0.36 | -$0.36 | 0.00% | $15.35M | $10.57M | $13.27M | 25.50% | 08/02/2022 | |
AQST | Aquestive Therapeutics | -$0.41 | -$0.41 | -$0.32 | 21.95% | $11.12M | $10.11M | $12.27M | 21.36% | 05/03/2022 | |
AQST | Aquestive Therapeutics | -$0.60 | -$0.47 | -$0.38 | 19.15% | $7.15M | $9.36M | $11.08M | 18.35% | 03/08/2022 | |
AQST | Aquestive Therapeutics | -$0.49 | -$0.45 | -$0.37 | 17.78% | $8.26M | $11.01M | $13.29M | 20.68% | 11/02/2021 | |
AQST | Aquestive Therapeutics | -$0.07 | -$0.44 | -$0.33 | 25.00% | $21.68M | $9.48M | $15.35M | 61.87% | 08/03/2021 | |
AQST | Aquestive Therapeutics | -$0.49 | -$0.43 | -$0.41 | 4.65% | $8.77M | $8.97M | $11.12M | 23.99% | 05/04/2021 | |
AQST | Aquestive Therapeutics | -$0.48 | -$0.26 | -$0.60 | -130.77% | $16.42M | $6.25M | $7.15M | 14.38% | 03/09/2021 | |
AQST | Aquestive Therapeutics | -$0.54 | -$0.46 | -$0.49 | -6.52% | $12.42M | $8.72M | $8.26M | -5.28% | 11/04/2020 |
Aquestive Therapeutics (AQST) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $-0.14 | $-0.18 | 22.2 % |
| Q1 | 2025-05-12 | $-0.24 | $-0.16 | -50.0 % |
| Q4 | 2025-03-05 | $-0.19 | $-0.13 | -46.2 % |
| Q3 | 2024-11-04 | $-0.13 | $-0.13 | 0.00 % |
Aquestive Therapeutics (AQST) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $10.00M | $11.22M | -10.8 % |
| Q1 | 2025-05-12 | $8.72M | $12.23M | -28.7 % |
| Q4 | 2025-03-05 | $11.87M | $13.11M | -9.48 % |
| Q3 | 2024-11-04 | $13.54M | $12.68M | 6.80 % |
FAQ
Quando Aquestive Therapeutics (NASDAQ:AQST) riporterà gli utili?
Si prevede che Aquestive Therapeutics (AQST) fornisca risultati il novembre 3, 2025. Gli ultimi risultati sono stati pubblicati il agosto 11, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Aquestive Therapeutics (NASDAQ:AQST)?
L'EPS effettivo era $-0.14, che superato la stima di $-0.18.
Quali sono state le entrate di Aquestive Therapeutics (NASDAQ:AQST)?
Le entrate effettive sono state $10M, che mancato la stima di $11.2M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.